Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Cell-free adipose tissue-derived stem cell extracts mediate immunosuppression of lymphocyte via cell cycle arrest.

Kamprom W., Tragoonlugkana P., Tangporncharoen R., Chitchongyingcharoen N., Permmee P., Pruksapong C.

Laboratory Study on Immune Modulation, published in Sci Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Sci Rep (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42151392
DOI
10.1038/s41598-026-53336-3

Abstract (original English)

Cell-free mesenchymal stem cell products have shown promise in reducing inflammation, alleviating tissue degeneration, and regulating immune responses. A recent study has reported that adipose tissue-derived stem cell (ADSC) extract possesses immunomodulatory capacity. However, its comparative efficacy against other cell-free products is not well documented. Nevertheless, the underlying mechanism of ADSC extract is under intense investigation. We determined the immunosuppressive efficiency of ADSC extract and ADSC-concentrated conditioned medium (CCM) on T cell proliferation, T regulatory cell expansion, and T cell cycle progression. In addition, the comparative cytokine profiles of ADSC extract and ADSC-CCM were investigated by cytokine array analysis. The ADSC extracts were superior in inhibiting T cell proliferation, promoting T regulatory cell expansion, and inducing activated T cell arrest at G0/G1 phase compared with ADSC-CCM. The inhibitory effect of ADSC extract on T cell proliferation was partly associated with control of cell cycle progression but not apoptosis induction. A halt in cell cycle progression of activated T lymphocyte after ADSC extract exposure was mediated via p21 and p27 activation. The cytokine profiling demonstrated that there were distinct patterns of immunoregulatory components in ADSC extract and ADSC-CCM, likely associated with their differing in

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdultHumansMiddle AgedCell Cycle CheckpointsCulture Media, ConditionedImmune ToleranceInterleukin-10Lymphocyte ActivationMesenchymal Stem CellsSubcutaneous Fat, Abdominal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research